Sprint Bioscience AB | Income Statement
Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Sales/Revenue
-
7,726.60
34,992.10
23,967.00
Cost of Goods Sold (COGS) incl. D&A
386.50
23,208.40
30,644.10
35,097.00
Gross Income
386.50
15,481.70
4,347.90
11,130.00
SG&A Expense
11,342.60
-
-
-
EBIT
11,729.10
15,481.70
4,347.90
11,130.00
Unusual Expense
-
-
2,884.50
-
Non Operating Income/Expense
469.90
124.90
3,161.90
509.00
Interest Expense
208.80
144.50
84.70
42.00
Pretax Income
11,463.60
15,500.10
4,540.90
10,663.00
Consolidated Net Income
11,463.60
15,500.10
4,540.90
10,663.00
Net Income
11,463.60
15,500.10
4,540.90
10,663.00
Net Income After Extraordinaries
11,463.60
15,500.10
4,540.90
10,663.00
Net Income Available to Common
11,463.60
15,500.10
4,540.90
10,663.00
EPS (Basic)
1.75
2.37
0.65
1.46
Basic Shares Outstanding
6,544.60
6,544.60
6,985.90
7,318.80
EPS (Diluted)
1.75
2.37
0.65
1.46
Diluted Shares Outstanding
6,544.60
6,544.60
6,985.90
7,318.80
EBITDA
11,342.60
15,273.70
4,799.20
10,566.00
Non-Operating Interest Income
4.40
1.30
0.20
-
About Sprint Bioscience AB
View Profile
